Tempus AI Inc. (NASDAQ:TEM) is one of the top 10 hidden AI stocks to buy. On May 31, Tempus AI launched the next generation ...

Tempus AI (NASDAQ:TEM) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ...

Financial giants have made a conspicuous bullish move on Tempus AI. Our analysis of options history for Tempus AI (NASDAQ:TEM) revealed 31 unusual trades. Delving into the details, we found 51% of ...

How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care ...

On Thursday, Tempus AI, Inc. (NASDAQ:TEM) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update ...

Arguing that investors should be circumspect about the company's financials and its public claims, Spruce Point Capital Management provided the market with a report that questions the credibility of ...

・Tempus AI is expanding its clinical oncology offering with the launch of ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. ・The tool combines digital pathology and genomic ...

Market snapshot and recent moves Tempus AI (TEM) has drawn fresh attention after a strong single-day move, with the stock up about 10% on the latest close at US$52.26, compared with weaker returns ...

Tempus AI will collaborate with Northwestern University's neurogenomics researchers to use artificial intelligence to accelerate discovery of treatments for Alzheimer's disease, the Chicago-based ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its ...